News

Thyroid eye disease shows long-term progression in data set

Research 50/100
July 28, 2026↗ source

New real-world data presented at ARVO challenges the historical belief that Thyroid Eye Disease (TED) stabilizes after 18 months. Analyzing records of over 34,000 patients, researchers found that nearly 30% experienced disease progression years after their initial diagnosis. These findings suggest that the clinical progression of TED may not strictly follow the traditional Rundle's Curve model.

Related peptides

Every claim on this page is sourced. Reliability scores are tier-capped and server-normalized (0–100; green ≥70, amber ≥40, red <40). Drill through to the source page to verify.